SARS-CoV-2 3CLpro-IN-2
SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases[1].
Product Specifications
CAS Number
[2765088-93-3]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-2.html
Purity
99.71
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CNC(CN1C(N/C(N(C1=O)CC2=CC(F)=C(C(F)=C2)F)=N\C3=C(C=C(C=C3)OC(F)F)C)=O)=O
Molecular Formula
C21H18F5N5O4
Molecular Weight
499.39
References & Citations
[1]Tyndall JDA. S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2. J Med Chem. 2022 May 12;65 (9) :6496-6498.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal SEC22B Antibody [Janelia Fluor 646]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Lentiviral human AKT1S1 shRNA (UAS) - Lentiviral human AKT1S1 shRNA (UAS, iRFP) plasmid